Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.48 USD | -1.99% | +5.71% | -86.38% |
Apr. 17 | Truist Adjusts Marinus Pharmaceuticals' PT to $10 From $25, Keeps Buy Rating | MT |
Apr. 16 | Baird Downgrades Marinus Pharmaceuticals to Neutral, Price Target at $2 | MT |
Financials (USD)
Sales 2024 * | 41.06M | Sales 2025 * | 62.09M | Capitalization | 81.29M |
---|---|---|---|---|---|
Net income 2024 * | -133M | Net income 2025 * | -93M | EV / Sales 2024 * | 1.98 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.31 x |
P/E ratio 2024 * |
-0.66
x | P/E ratio 2025 * |
-1.12
x | Employees | 166 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.02% |
Latest transcript on Marinus Pharmaceuticals, Inc.
1 day | -1.99% | ||
1 week | +5.71% | ||
Current month | +4.96% | ||
1 month | -81.03% | ||
3 months | -85.20% | ||
6 months | -77.58% | ||
Current year | -86.38% |
Managers | Title | Age | Since |
---|---|---|---|
Scott Braunstein
CEO | Chief Executive Officer | 60 | 18-09-04 |
Steven Pfanstiel
DFI | Director of Finance/CFO | 51 | 21-04-11 |
Joseph Hulihan
CTO | Chief Tech/Sci/R&D Officer | 68 | 19-11-05 |
Members of the board | Title | Age | Since |
---|---|---|---|
Tim Mayleben
BRD | Director/Board Member | 63 | 08-11-30 |
Scott Braunstein
CEO | Chief Executive Officer | 60 | 18-09-04 |
Elan Ezickson
BRD | Director/Board Member | 60 | 19-12-11 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.96% | 11 M€ | -6.03% | - | |
0.02% | 0 M€ | 0.00% | - | |
0.02% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-06 | 1.48 | -1.99% | 1,572,928 |
24-05-03 | 1.51 | +4.14% | 1,620,694 |
24-05-02 | 1.45 | -1.36% | 989,641 |
24-05-01 | 1.47 | +4.26% | 2,304,865 |
24-04-30 | 1.41 | +0.71% | 1,365,206 |
Delayed Quote Nasdaq, May 06, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-86.38% | 82.93M | |
+31.52% | 662B | |
+21.96% | 546B | |
-5.21% | 359B | |
+17.02% | 323B | |
+5.01% | 289B | |
+13.68% | 234B | |
+3.81% | 198B | |
-10.63% | 194B | |
+3.98% | 167B |
- Stock Market
- Equities
- MRNS Stock